JP2012524725A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012524725A5 JP2012524725A5 JP2012506297A JP2012506297A JP2012524725A5 JP 2012524725 A5 JP2012524725 A5 JP 2012524725A5 JP 2012506297 A JP2012506297 A JP 2012506297A JP 2012506297 A JP2012506297 A JP 2012506297A JP 2012524725 A5 JP2012524725 A5 JP 2012524725A5
- Authority
- JP
- Japan
- Prior art keywords
- klk1
- seq
- pharmaceutical composition
- polypeptide
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17157909P | 2009-04-22 | 2009-04-22 | |
| US61/171,579 | 2009-04-22 | ||
| PCT/CA2010/000575 WO2010121361A1 (en) | 2009-04-22 | 2010-04-22 | Tissue kallikrein for the treatment of huntington's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012524725A JP2012524725A (ja) | 2012-10-18 |
| JP2012524725A5 true JP2012524725A5 (https=) | 2013-05-30 |
Family
ID=43010630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012506297A Pending JP2012524725A (ja) | 2009-04-22 | 2010-04-22 | ハンチントン病を治療するための組織カリクレイン |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120225051A1 (https=) |
| EP (1) | EP2421554A4 (https=) |
| JP (1) | JP2012524725A (https=) |
| CN (1) | CN102458454A (https=) |
| CA (1) | CA2759490A1 (https=) |
| WO (1) | WO2010121361A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2182978A4 (en) | 2007-07-20 | 2012-03-21 | Sanomune Inc | TISSUE KALLIKREIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID PROTEIN |
| US20130315891A1 (en) * | 2012-05-25 | 2013-11-28 | Matthew Charles | Formulations of human tissue kallikrein-1 for parenteral delivery and related methods |
| EP2854841B1 (en) | 2012-06-04 | 2017-02-22 | Diamedica Inc. | Human tissue kallikrein 1 glycosylation isoforms |
| WO2015109107A1 (en) * | 2014-01-15 | 2015-07-23 | Cal Poly Pomona Foundation, Inc. | Treatment and diagnosis of huntington's disease |
| CN110446501A (zh) | 2017-03-09 | 2019-11-12 | 代阿麦迪卡股份有限公司 | 组织激肽释放酶1的剂型 |
| CN116549619A (zh) * | 2022-01-28 | 2023-08-08 | 江苏众红生物工程创药研究院有限公司 | 激肽原酶及其衍生物在治疗vci、psci或csvd中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001056532A2 (en) * | 2000-02-04 | 2001-08-09 | The Scripps Research Institute | Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc) |
| US20070191296A1 (en) * | 2003-08-30 | 2007-08-16 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with kallikrein 13 (klk13) |
| EP1664790A2 (en) * | 2003-08-30 | 2006-06-07 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with kallikrein 8 (klk8) |
| EP2182978A4 (en) * | 2007-07-20 | 2012-03-21 | Sanomune Inc | TISSUE KALLIKREIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID PROTEIN |
-
2010
- 2010-04-22 CA CA2759490A patent/CA2759490A1/en not_active Abandoned
- 2010-04-22 US US13/265,357 patent/US20120225051A1/en not_active Abandoned
- 2010-04-22 EP EP10766547A patent/EP2421554A4/en not_active Withdrawn
- 2010-04-22 CN CN2010800275339A patent/CN102458454A/zh active Pending
- 2010-04-22 JP JP2012506297A patent/JP2012524725A/ja active Pending
- 2010-04-22 WO PCT/CA2010/000575 patent/WO2010121361A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2661500T3 (es) | Variantes de HMGB1 y sus usos | |
| JP2012524725A5 (https=) | ||
| CN103476933B (zh) | 白介素1受体的拮抗剂 | |
| RU2013139651A (ru) | Новые соединения, влияющие на пищевое поведение | |
| JP2014521684A5 (https=) | ||
| NZ602824A (en) | Sparc binding peptides and uses thereof | |
| HRP20140616T1 (hr) | Peptidni analog oksintomodulina | |
| JP2012041342A5 (https=) | ||
| JP2012530073A5 (https=) | ||
| JP2015512927A5 (https=) | ||
| HRP20161560T1 (hr) | Varijanta, rekombinantnih proteina beta-glukocerebrozidaze s povećanom stabilnošću i povećanom zadržanom katalitičkom aktivnošću | |
| AU2019272030A1 (en) | Promoting epithelial regeneration post tonsillectomy using heparin binding epidermal growth factor like growth factor | |
| JP2020502151A5 (https=) | ||
| US12214024B2 (en) | Use of APC analogue for wound healing | |
| US12552848B2 (en) | Hydrochloride salts of C5a receptor agonist peptides | |
| ES3048450T3 (en) | Components of the plasminogen activation pathway for use in the treatment of hypertension | |
| JP2007521333A5 (https=) | ||
| JP2014515595A5 (https=) | ||
| KR20230052929A (ko) | 종양 치료 방법 및 약물 | |
| JP2014512369A5 (https=) | ||
| AU2019202876B2 (en) | Administration of Recombinant Collagen 7 for the Treatment of Age Related Disorders | |
| Huang et al. | Efficacy of granulocyte-colony stimulating factor treatment in a rat model of anterior ischemic optic neuropathy | |
| JP2019512216A5 (https=) | ||
| JP2019524089A5 (https=) | ||
| JP2018510213A5 (https=) |